Dual antiplatelet therapy for three months followed by monotherapy is non-inferior to one year dual antiplatelet therapy in acute coronary syndrome patients undergoing percutaneous coronary intervention-A systematic review and meta-analysis

Category Systematic review
JournalCirculation
Year 2019
This article has no abstract
Epistemonikos ID: da7cb16a91bfa1b7e39378bbcadbc2bcd677a0c5
First added on: Feb 11, 2025